SKYAI INC

Explore SKYAI INC’s journey from Sharps Technology to a Nasdaq‑listed leader in syringes and safety medical devices, and discover why investors are watching its volatile yet promising stock.

SkyAI Inc. slides to $1.12 after a sharp fall from $18.23, facing new support near $0.055 and negative PE—investors weigh a possible reversal.

SkyAI token surges: see key MA levels, trading volume spikes, and potential consolidation risks for investors.

SkyAI’s latest SEC 8‑K shows the board rejected Forward Industries’ all‑stock merger, keeping the Nasdaq‑listed company independent and stable.

SKYAI Inc. (SKYA) jumps 10% as Solana‑linked digital‑asset treasuries rally, spotlighting the company’s Solana‑based strategy and growing index interest.

SkyAI’s board faces a 20 % premium all‑stock merger bid from Forward Industries, sparking a 15 % stock surge and raising questions about future consolidation in the Solana ecosystem.